Millennium Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-300,000
Closed -$666K 6189
2024
Q2
$666K Buy
+300,000
New +$706K ﹤0.01% 4411
2024
Q1
Sell
-194,500
Closed -$582K 6278
2023
Q4
$582K Sell
194,500
-5,500
-3% -$7.13K ﹤0.01% 4548
2023
Q3
$196K Hold
200,000
﹤0.01% 5134
2023
Q2
$278K Sell
200,000
-300,000
-60% -$419K ﹤0.01% 4938
2023
Q1
$795K Buy
500,000
+252,500
+102% +$1.3M ﹤0.01% 4293
2022
Q4
$1.54M Buy
+247,500
New +$1.77M ﹤0.01% 3778
2021
Q2
Sell
-50,000
Closed -$1.4M 6658
2021
Q1
$1.4M Buy
+50,000
New +$1.48M ﹤0.01% 3861
2020
Q4
Sell
-50,000
Closed -$1.86K 5292
2020
Q3
$1.86K Sell
50,000
-50,000
-50% -$1.98M ﹤0.01% 2652
2020
Q2
$5.13M Buy
+100,000
New +$4.18M 0.01% 1743
2019
Q3
Sell
-50,000
Closed -$2.33M 4270
2019
Q2
$2.33M Sell
50,000
-60,000
-55% -$2.82M ﹤0.01% 2313
2019
Q1
$4.42M Buy
+110,000
New +$4.93M 0.01% 1860
2017
Q1
Sell
-150,000
Closed -$1.88M 3571
2016
Q4
$1.88M Buy
+150,000
New +$1.79M ﹤0.01% 1913

Other funds holding ESPR